Main Navigation

Dr. Truman Milling, LSS PI, publishes research on use of FXa inhibitors

AUSTIN – May 10, 2017 – Dr. Truman Milling of our Seton Healthcare hub in Austin recently published an article on the unmet need for a reversal agent for the management of FXa inhibitor-associated bleeding. The study, with co-author Dr. Jennifer Frontera, was published in the American Journal of Managed Care.

Exploring Indications for the Use of Direct Oral Anticoagulants and the Associated Risks of Major Bleeding

 

 

Facebook
Twitter
EMAIL